PUT - SPRINTER OPEN END - MEDTRONIC Share Price

Certificat

DE000VD6TWW4

Market Closed - Boerse Frankfurt Warrants 18:55:31 28/06/2024 BST
0.51 EUR -10.53% Intraday chart for PUT - SPRINTER OPEN END - MEDTRONIC
Current month+34.21%
1 month+96.15%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 0.51 -10.53%
27/06/24 0.57 +16.33%
26/06/24 0.49 +6.52%
25/06/24 0.46 +21.05%
24/06/24 0.38 0.00%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 06:55 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VD6TWW
ISINDE000VD6TWW4
Date issued 24/05/2024
Strike 84.33 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.33
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.57
Lowest since issue 0.085

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus